HFA Welcomes Dan Kelsey as Chief Executive Officer

Dan Kelsey Headshot

Experienced executive brings outcome-driven leadership to the national nonprofit patient advocacy group. 

WASHINGTON, DC, April 12, 2023 – The Board of Directors of Hemophilia Federation of America (HFA) unanimously selected Dan Kelsey as HFA’s new Chief Executive Officer (CEO) on April 7, 2023. Dan will join the HFA team on Wednesday, April 12 and attend their annual Symposium in Orlando, Florida.  

Dan was first introduced to the bleeding disorders community early in his nonprofit career when he worked on database projects for Hemophilia of Indiana and the Indiana Hemophilia and Thrombosis Center while employed at the Indiana State Medical Association in the areas of membership and payer advocacy. He also worked with the Indiana Medicaid program as a field representative and healthcare consultant in compliance, accounts receivable reviews, and various commercial payer issues. Dan has had vast experience working with statewide physician groups and associations over the past two decades. As previous Deputy CEO to a national physician specialty association and CEO of a national association focused on medical imaging and leadership, Dan brings a wealth of knowledge and experience to every facet of the organization. 

“I am honored to be chosen as HFA’s next CEO. This team represents the values, collaboration and dedication required to strengthen the organization and lead by example as a patient advocacy group for rare diseases,” says Dan Kelsey. “I look forward to bringing a fresh perspective and new technologies to the work in order to deliver first-in-class outcomes for the bleeding disorders community.” 

“Dan brings over 20 years of medical membership association, nonprofit and data systems experience to HFA. He has successfully led other organizations through key transitions and has inspired technological innovation,” says Luke Runion, Chair of HFA. “Dan currently serves as Chair of the American Society of Association Executives HealthCare Advisory Subcommittee, which gives him unique insight into the issues impacting nonprofit organizations like HFA. The HFA Board of Directors is delighted to have Dan lead HFA and its staff in support of the bleeding disorders community.” 

HFA is a community-based, patient-centered organization that advocates for the needs of families living with debilitating bleeding disorders. The primary goal of HFA is to advocate for safe and effective therapies, quality, affordable health coverage and better quality of life for all persons with bleeding disorders.